Koers Stemcell Holdings, Inc. Other OTC
Aandelen
STMM
US85858N2027
Farmaceutische producten
Omzet 2016 | 3,34 mln. 3,09 mln. | Omzet 2017 | 6,18 mln. 5,72 mln. | Marktkapitalisatie | 1,64 mln. 1,52 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | 1 mln. 926K | Nettowinst (verlies) 2017 | 2 mln. 1,85 mln. | EV/omzet 2016 * | - |
Nettoliquiditeiten 2016 * | - 0 | Nettoliquiditeiten 2017 * | - 0 | EV/omzet 2017 * | - |
K/w-verhouding 2016 * |
-
| K/w-verhouding 2017 * |
-
| Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 * |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,82% | 91,94 mld. | |
-1,32% | 38,74 mld. | |
-12,88% | 32,82 mld. | |
+64,77% | 26,66 mld. | |
-16,31% | 15,32 mld. | |
-5,78% | 13,3 mld. | |
-11,38% | 11,65 mld. | |
+173,10% | 10,37 mld. | |
-49,84% | 10,12 mld. |